生物标志物在变应性鼻炎特异性免疫治疗疗效评价中的应用
Application of biomarker in evaluating the efficacy of specific immunotherapy for allergic rhinitis
特异性免疫治疗(specific immunotherapy,SIT)已成为变应性鼻炎的一线疗法,但仍有大约40%的SIT患者疗效无法预估.目前为止尚缺乏评价免疫治疗疗效的特异性指标.本文就评价变应性鼻炎SIT疗效的可能相关因子进行综述.
更多Specific immunotherapy (SIT) has become the first-line treatment of allergic rhinitis,but still 40% of patients with SIT can't predict the efficacy.So far,there is no specific index to evaluate the efficacy of immunotherapy.This review summarizes the possible relevant factors for evaluating the efficacy of specific immunotherapy for allergic rhinitis.
More- 浏览:203
- 被引:5
- 下载:164
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文